What CIWA‑Ar (Clinical Institute Withdrawal Assessment for Alcohol) monitoring protocol should be used for a patient who drinks 24 oz of beer four times daily?

CIWA-Ar Protocol for Heavy Daily Alcohol Use

This patient requires inpatient admission with symptom-triggered CIWA-Ar monitoring every 1-2 hours initially, with benzodiazepine treatment initiated when scores reach ≥8.

Quantifying the Drinking Pattern

This patient consumes approximately 96 oz of beer daily (24 oz × 4 times/day), which equals:

• 8-9 standard drinks per day (using US standard: 12 oz beer = 1 drink)
• Approximately 112-126 grams of pure alcohol daily
• 784-882 grams per week

This far exceeds heavy drinking thresholds (>210g/week for men, >112g/week for women) and represents severe alcohol use disorder with high physiological dependence 1, 2.

Risk Assessment and Setting of Care

Inpatient treatment is mandatory for this patient due to:

• Extremely high daily consumption indicating severe dependence
• Substantial risk of complicated withdrawal (seizures, delirium tremens)
• Need for frequent vital sign monitoring and rapid intervention capability 3

The 6-24 hour window after last drink is when withdrawal symptoms typically emerge, with peak severity at 3-5 days 1.

CIWA-Ar Monitoring Protocol

Initial Phase (First 24-48 hours)

• CIWA-Ar assessments every 1-2 hours while patient is awake
• Continue frequent monitoring until scores stabilize below 8 for 24 hours 4, 5

Scoring Thresholds and Actions

• CIWA-Ar <8: Monitoring only, no pharmacological treatment needed
• CIWA-Ar 8-15: Moderate withdrawal - initiate standard benzodiazepine dosing
• CIWA-Ar ≥15: Severe withdrawal - increased benzodiazepine doses required 1, 4

Transition to Less Frequent Monitoring

Once scores remain consistently <8, assessments can be reduced to every 4-8 hours for an additional 48 hours before discontinuation 5, 6.

Pharmacological Management

Benzodiazepine Selection

For patients without liver disease:

• Long-acting benzodiazepines (diazepam 10-20mg or chlordiazepoxide 50-100mg every 4-6 hours as needed based on CIWA-Ar scores)
• These provide superior seizure and delirium tremens prevention 1, 3

If liver dysfunction, elderly, or respiratory compromise present:

• Lorazepam 2-4mg every 4-6 hours (intermediate-acting, no active metabolites)
• Starting dose 6-12mg/day total, tapered as symptoms resolve 3

Symptom-Triggered vs Fixed-Schedule Dosing

Use symptom-triggered regimen (dosing based on CIWA-Ar scores) rather than fixed schedules because:

• Reduces total benzodiazepine exposure by 40-50% 5, 6
• Decreases treatment duration from 4.7 to 2.2 days 6
• Prevents drug accumulation and oversedation 1
• Maintains equivalent safety with no increase in seizures or delirium tremens 5, 6

Essential Adjunctive Treatment

Thiamine 100-300mg daily must be administered to all patients, continued for 2-3 months after withdrawal resolution to prevent Wernicke encephalopathy 3. Give before any glucose-containing IV fluids to avoid precipitating acute deficiency.

Critical Monitoring Parameters

Beyond CIWA-Ar scores, closely monitor for:

• Vital signs every 1-2 hours initially (tachycardia, hypertension, fever indicate autonomic hyperactivity)
• Electrolyte abnormalities (especially magnesium, potassium)
• Dehydration status
• Comorbid conditions: hepatic encephalopathy, GI bleeding, pancreatitis, infection 3

Important Caveats

CIWA-Ar limitations to recognize:

• Requires cooperative, communicative patient - contraindicated if confused, intubated, or uncooperative 3, 4, 7
• Can be falsely elevated by anxiety disorders, sepsis, hepatic encephalopathy, or severe pain 3
• Not a diagnostic tool - diagnosis of alcohol withdrawal is clinical 3
• Requires trained staff for accurate administration 4, 7
• 14-20% of protocols are inappropriately ordered for patients who cannot communicate 7

Common pitfall: Approximately 19-38% of patients placed on CIWA-Ar protocols have inadequate documentation of alcohol use or withdrawal risk factors 7. Always confirm recent heavy use and physiological dependence before initiating.

Duration of Treatment

• Benzodiazepines should be limited to 10-14 days maximum due to abuse potential, particularly high in patients with alcohol use disorder 1
• Most patients complete withdrawal management within 3-5 days using symptom-triggered protocols 5, 6

Post-Withdrawal Planning

Psychiatric consultation is strongly recommended for evaluation of alcohol use disorder severity and long-term abstinence planning 3. This patient's consumption pattern indicates severe AUD requiring ongoing addiction treatment beyond acute withdrawal management.